Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2024RPS Pharmacy and Pharmacology ReportsOpen Access

Pattern of CYP3A5 and MDR-1 single nucleotide polymorphism and its impact on Tacrolimus levels and clinical outcomes in living renal allograft recipient

View Full Paper
Ask AI
Bookmark
Share

Authors

SSSukhwinder Singh SanghaSYSushma YadavRYRaj Kanwar Yadav

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sangha et al. (2024) studied this question.

synapsesocial.com/papers/68e71702b6db64358768fe59https://doi.org/10.1093/rpsppr/rqae016
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effect of gene polymorphisms on the levels of calcineurin inhibitors in Indian renal transplant recipients2010 · 25 citations
  2. 2The Global role of kidney transplantation2012 · 28 citations
  3. 3CYP3A-status is associated with blood concentration and dose-requirement of tacrolimus in heart transplant recipients2021 · 21 citations
  4. 4Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics2022 · 39 citations
  5. 5Influence of <i>CYP3A5</i> Genetic Polymorphism on Tacrolimus Daily Dose Requirements and Acute Rejection in Renal Graft Recipients2008 · 113 citations